Cancer is a disease which has long been shrouded in mystery, but our knowledge of its intricacies has been extended in numerous directions by investigations carried on in all parts of the world by workers in many branches of science. Yet it remains true that in general we are not able to explain the origin of cancer, and the methods of treatment at present available are pitifully inadequate. These facts provide ample justification for the most painstaking and persistent pursuit, with all the resources that can be brought to bear upon them, of any clues that may be forthcoming, however slender and unpromising they may seem to be.
One of the most fruitful lines of cancer research in recent years has provided the demonstration that cancer may be produced at will in a majority of the animals treated, with a variety of chemical compounds. For the most part these compounds have been prepared synthetically and their molecular structure is known. They retain their activity undiminished after a high degree of purification. The cancers which may thus be induced experimentally are indistinguishable in their characteristics from the cancers which afflict mankind. Histologically they conform to many different types; they can arise in a variety of organs in the body, and they show the accepted criteria of malignancy, such as invasion of normal tissue and the production of secondary growths. We are not, of course, justified in inferring from this that human cancer is of chemical origin. All we can say is that there are a large number of experimental observations which are consistent with the view that the factor which initiates the onset of malignancy may in some cases be a chemical compound or compounds. Indeed, it is now an established fact that the aestrogenic hormones, which are relatively simple chemical compounds of normal occurrence in the body, can play a role in the xtiology of certain specific types of experimental cancer, namely, carcinoma of the mamma in mice. In some circumstances, however, it seems likely that hereditary factors play an even greater part in this form of cancer and it would be premature to suggest that excessive secre-* A lecture given at Yale University on June 9th, 1938, under NO. 1 tion of cestrogenic hormones is the controlling factor in the development of similar cancers in women. Nevertheless, there are strong indications that these hormonal factors are worthy of attention in the study of cancer.
Another fact of great interest is the relative ease with which such naturally occurring compounds of widespread occurrence as cholesterol and the bile acids may be chemically transformed in vitro into a, compound which can act regularly and powerfully in inducing cancer experimentally. The malignant tumours formed under the influence of this sterol transformation product usually arise locally at the site of application. We are thus presented with the interesting speculation that cancer may be a disease of faulty metabolism caused by the abnormal degradation of sterol-like compounds to chemical agents which can initiate malignancy. This conception is susceptible to experimental investigation, although numerous technical difficulties arise and it may be years before it is possible to secure conclusive proof or disproof. Also, a large volume of work of outstanding importance and merit has been turned out from a number of Japanese laboratories. The Japanese workers have followed up clues first provided by B. Fischer as early as 1906. Fischer had shown that the injection of Scarlet Red (Biebrich Scarlet R medicinal) into the ears of rabbits led to an epithelial proliferation very like cancer, but it was not malignant. This discovery led to the employment of this dyestuff to accelerate wound-healing, in which connection it was subsequently found that the active part of the molecule was contained in o-aminoazotoluene (4'-amino-2: 3'-azotoluene). To Yoshida is due the credit of demonstrating that o-aminoazotoluene is a carcinogenic agent. Unlike the polycyclic hydrocarbons to be discussed later this azo compound gives no tumours either of the skin or at the site of subcutaneous injection, but gives cancer of the liver when fed in large doses to rats and mice, and also after subcutaneous injection. In addition, this aminoazotoluene was found to give papilloma of the urinary bladder in some of the rats to which it was fed. The related 2: 3'-azotoluene was shown by Otsuka and Nagao to have a much more pronounced carcinogenic action on the urinary bladder when administered to rats with their food, but no longer gave cancer of the liver. Nagao also found that the related 4'-hydroxy-2: 3'-azotoluene gave papilloma of the bladder in rats. Finally, Kinosita has shown that p-dimethylaminoazobenzene, isomeric with o-aminoazotoluene, is carcinogenic towards the liver, and also gave tumours of the stomach in some of the animals to which it was fed. Fortunately the name applied to this last compound, namely, "butter yellow," no longer has the significance which formerly attached to it. It is unlikely that this compound is now used as a food colouring matter. It has been known since the eighteenth century that certain forms of skin cancer constitute an industrial disease to which workers engaged in specific occupations are specially liable. This was first recognised in the so-called chimney-sweepers' cancer which a London surgeon, Percival Pott, described as being due to repeated contact of the skin with soot. The carcinogenic principle of the soot may, in fact, be extracted with ether and can be used to produce cancer of the skin in mice, as was first shown by Passey in 1922. The liability to industrial skin cancer is shown also by operatives engaged in handling coal tar and coal tar products, shale distillates and products obtained therefrom, and many mineral lubricating oils. In the case of coal tar the main component responsible for the cancerproducing properties has been isolated and synthesised in the laboratories of the Royal Cancer Hospital; it was shown to be 3: 4-benzpyrene by the following scheme of synthesis:
In this scheme the position attacked in the Friedel-Crafts reaction between pyrene and succinic anhydride is assumed by analogy.
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This does not affect the validity of the conclusion regarding the structure of the final pentacydic hydrocarbon, however, as only two benzpyrenes are theoretically possible, and the alternative 1: 2-benzpyrene, different from that obtained in the above synthesis, was prepared by another method which left no doubt as to its structure.
In the experiments leading to the isolation of benzpyrene from coal tar, studies of fluorescence spectroscopy, initiated by Mayneord and continued by Hieger, played an important part. 3:4-Benzpyrene is characterised by a very powerful and persistent violet fluorescence, the spectrum of which appears to consist of three characteristic bands if examined at low dispersions. These same bands were detected in many complex carcinogenic mixtures, including not only coal tar and its products, but also a mixture obtained by Schroeter by the action of aluminium chloride on tetralin, and shown by Kennaway to be carcinogenic. Probably 3: 4-benzpyrene is present in this mixture, and although it has not been conclusively demonstrated that the same hydrocarbon is the active carcinogenic agent present in shale oil and other lubricating oils, the available evidence makes it inherently probable that the active compound is either 3: 4-benzpyrene or a closely related compound.
The powerful fluorescence of benzpyrene, with its characteristic spectrum, has been utilised by several investigators who have made experimental studies of its behaviour in the animal body. Allusion may be made in particular to the work of Peacock, who injected aqueous colloidal solutions of benzpyrene intravenously into rabbits, guinea-pigs, mice, and fowls. He found that the body fats gave the fluorescence spectrum of benzpyrene within 15 to 30 minutes after injection, and fluorescent droplets appeared in the liver cells. During the few hours which succeeded, fluorescence appeared in the bile, but the spectrum was different from that of benzpyrene, indicating that chemical transformation, possibly not of an extensive character, had taken place.
At this stage reference may be made to the manner in which the carcinogenic properties of benzpyrene may be demonstrated. Similar considerations apply also to the other polycyclic hydrocarbons which have been found carcinogenic. The main differences between them are quantitative rather than qualitative. That is to say, the compounds give tumours of similar types, in the same organs, with similar degrees of malignancy. They differ, however, in the rapidity with which tumours arise, and in the proportion of the animals which develop tumours. 3: 4-Benzpyrene is one of the more active carcinogenic compounds, and if a drop of a 0.3 per cent solution in benzene is applied twice a week to the back of a mouse tumours begin to appear after about 80 to 100 days. With certain other compounds this latent period is rather less than this, but with the majority of them it is greater and may be as much as 300 to 400 days or even more. The first visible signs of tumours consist of the appearance of one or more small warts on the skin. These grow, usually fairly rapidly, and where there are several they often coalesce into one large horny mass of tumour which at the same time penetrates the deeper tissues of the animal, showing invasion of muscle and other criteria of malignancy. Such tumours are epitheliomas which belong to the class of malignant tumours known as carcinomas. These are usually squamous-celled in character, but have sometimes been spindle-celled. If the same compound is injected into the subcutaneous tissues of the rats, mice, or fowls, then rapidly growing spindle-celled tumours arise which conform to the type of cancer known as sarcoma. It has been made clear from these results that the principal etiological differences between carcinomas and sarcomas lie in the tissues which give rise to the malignant cells.
Methylcholantthrene
Another carcinogenic hydrocarbon which merits special consideration is methylcholanthrene. As is perhaps apparent from its name, this hydrocarbon is related to the cholane (bile acid) group of natural products and it was in fact first obtained from deoxycholic acid (i.e., 3: 12-dihydroxycholanic acid) independently by Wieland and Dane and also by Haslewood and myself. The changes involved in this transformation are all of a comparatively simple type and it appeared of some significance that this bile acid has in its molecule a hydroxyl group in a suitable position to facilitate cyclisation of the aliphatic side chain to give rise to a ring system which was already known to be associated with carcinogenic properties. Proof that such cyclisation does, in fact, occur in vivo is still lacking and this applies also with regard to the extensive dehydrogenation of the ring system which appears necessary for the development of carcinogenic properties.
Fieser subsequently showed that methylcholanthrene could be obtained also by similar reactions from cholic acid (3: 7: 12-trihydroxycholanic acid). Cholic acid and deoxycholic acid comprise the principal acids of human bile. Even greater interest attaches to the recent observations of Rossner, working in Windaus's laboratory, who found that methylcholanthrene could be obtained by dehydrogenation with selenium at 3600 of the complex hydrocarbazole derivatives which are formed by condensation of cholestenone and cholestanone with phenylhydrazine. In the complex reactions which accompany dehydrogenation the nitrogenous portion of the molecule and part of the side chain are simultaneously eliminated.
Hydrocarbazole derivative Methyicholanthrene from cholestanone
It seems to me that this reaction, involving a sterol derivative in which, unlike the bile acids, hydroxy groups are not present to promote cyclisation, indicates an inherent tendency on the part of the sterol side chain to undergo cyclisation to a hydrogenated methylcholanthrene derivative, and the implications of this view are worthy of widespread experimental study. The structure of methylcholanthrene was established by the synthesis of its degradation product, 5: 6-dimethyl-1: 2-benzanthraquinone. Additional confirmation was afforded by the synthesis of methylcholanthrene itself by Fieser and Seligman. This synthesis consists in pyrolysis of the ketone arising from the interaction of 1-naphthylmagnesium bromide with 7-cyano-4-methylhydrindene, and by this method it is possible to prepare considerable amounts of methylcholanthrene. The parent hydrocarbon, cholanthrene, which
CH3t 9CH
is likewise a potent carcinogenic compound, has been synthesised by four different methods. One of these, due to Haslewood and myself, takes advantage of the fact that ,3-alkyl-naphthalenes are brominated mainly in the contiguous a-position, and the final stages are as follows:
Cho lanthrene
Fieser and his colleagues have synthesised a series of compounds designed to determine the structural features of the methylcholanthrene molecule which are necessary for carcinogenic activity. This work has overlapped to some extent with investigations of benzanthracene derivatives which have been in progress in my laboratory for several years, and we may at this stage discuss the relationships between molecular structure and carcinogenic activity which have been established among the benzanthracene derivatives.
We first became interested in benzanthracene derivatives in this connection as a result of the spectroscopic investigations of Mayneord and Hieger, who found that the fluorescence spectrum of 1: 2-benzanthracene bore considerable resemblance to that of carcinogenic tars. As stated above, this latter spectrum was afterwards shown to be due to 3: 4-benzpyrene. As the result of this resemblance the synthesis of new benzanthracene derivatives was initiated in our laboratory, in the hope of procuring compounds which would t 'T TI give a spectrum resembling even more closely that of the cancer-producing tars. In the meantime the finding of Kennaway that 1:2-Banzanthracene 1: 2: 5: 6-dibenzanthracene had cancer-producing activity gave a very powerful stimulus to these synthetic studies, and we now have a considerable range of carcinogenic derivatives of 1: 2-benzanthracene, which include 3: 4-benzpyrene and methylcholanthrene, both of which are seen to be benzanthracene derivatives.
It would be wearisome to attempt to catalogue the compounds which have been prepared and tested in the course of this work, but it is of interest to consider the relationships that have emerged as the result of a study of one series of compounds, namely, the methylbenzanthracenes. There are 12 possible positions of monosubstitution in the unsymmetrical molecule of 1: 2-benzanthracene, and the synthesis of the 12 monomethyl compounds, begun early in 1930, has been completed within the last few months. The first generalisation which emerged during the course of this work was that substitution in certain positions could transform the biologically inactive parent hydrocarbon into carcinogenic compounds, whereas substitution in the other positions was without influence. At quite an early stage it became evident that positions 5 and 6 were favourable positions of substitution for the manifestation of carcinogenic activity. This has been confirmed by a study of compounds with substituents other than methyl groups. It was found further that substituents in both these positions produced greater activity than a single substitution in either position. This is illustrated by the marked carcinogenic activity of 5: 6-dimethyl-1: 2-benzanthracene, 5: 6-cyclopenteno-1: 2-benzanthracene, and 1: 2: 5: 6-dibenzanthracene.
An important development which occurred during the past year was the recognition that the two meso positions 9 and 10 are also favourable positions of substitution for the development of carcinogenic properties. The meso methyl benzanthracenes necessary for these studies were synthesised independently at almost the same time at Harvard and in London, and from the results now available the most potent of the monomethyl benzanthracenes is undoubtedly the 10-compound, which gives sarcomas almost as rapidly as the cholanthrene hydrocarbons when injected into mice, but is rather less rapid than these compounds in the production of skin tumours. Thus, of the twelve monomethyl benzanthracenes four (with substituents at positions 5, 6, 9, and 10) have pronounced carcnogenic properties. Of the other eight, the 3-methyl compound gave no skin tumours in mice, but has given subcutaneous tumours when injected; the 8-methyl compound has been under test for such a short time that no opinion can yet be expressed as to carcinogenic activity; the remaining six compounds seem to be inactive.
The carcinogenic activity of the meso methyl benzanthracenes provides at once a direct correlation between the potent carcinogenic compounds 3: 4-benzpyrene and methylcholanthrene, for the former is a 9-substituted benzanthracene derivative, and the latter a 1 0-substituted derivative. Moreover, it has become increasingly apparent that the presence of substituents in more than one favourable position tends to be an additive effect. Fieser has shown that 5: 10-dimethyl-1: 2-benzanthracene is more potent than either the 5-or 1 0-monomethyl compounds, and Newman has found that a similar consideration applies to 5: 9-dimethyl-1: 2-benzanthracene. In the light of these facts it is not surprising that methylcholanthrene, with simple substituents in no less than 3 favourable positions should be such a potent cancer-producing compound. Also, it was clearly of interest to examine 9: 1 0-dimethyl-1: 2-benzanthracene. We were occupied with the synthesis of this compound when we learned from Dr. Bachmann, of the University of Michigan, that he had prepared it and we have carried out tests with a specimen synthesised by him. The results have been little short of spectacular. In scarcely more than 30 days tumours began to appear on the skin of the mice to which this compound was applied. This is less than half the time required for tumour formation with methylcholanthrene. The mice used in this test were also characterised by the simultaneous appearance of a number of warts on each animal, averaging about 4 per mouse. Subsequent histological examination showed that these tumours were genuine epitheliomas, and from the standpoint of rapidity of action this new hydrocarbon (9: 1 0-dimethyl-1: 2-benzanthracene) is by far the most potent synthetic carcinogenic compound yet obtained. It is clear from the results which have been reviewed that carcinogenic activity among the benzanthracene homologues is a property partly determined by, and dependent upon, molecular structure.
Influence of Structural Modification on Carcinogenic Activ'ity
Numerous compounds related to the carcinogenic hydrocarbons have now been tested for cancer-producing properties, and although a number of interesting relationships have emerged it is difficult to correlate the effects of structural alteration. On the one hand comparatively slight changes may have a profound influence on carcinogenic activity, while on the other hand it has frequently been found that activity is retained after quite gross alterations of structure.
In general, it appears that the activity is primarily determined by the superficial form of the molecule, but at the same time it is obvious that details of structure may be very important.
Hydrogenation of the aromatic ring system contained in the carcinogenic hydrocarbons is usually attended by complete loss of activity, although it seems likely that slight activity is retained by certain dihydro compounds which may, however, exert this activity by virtue of their ready dehydrogenation to the aromatic structure. Simple alkyl groups, which, as we have seen, may under favourable conditions promote carcinogenic activity, will often have an adverse effect on the activity of a potent compound. There are several examples of derivatives of 1: 2: 5: 6-dibenzanthracene which support this thesis, and Winterstein has described an inactive methyl 3:4:5:6-dibenzacridine 1:2:5:6-dibenzfluorene 1:2:5:6-dibenzacridine"
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:~~~~~~~~~1256-dibenz-3:4:5:6-diben2carbazole carbazble 1:2: 7:8-dibenzcarbazole 1:2: 5:6-dibenzphenazine derivative of the highly active 3: 4-benzpyrene. The effect of addition of another ring is usually to destroy activity (e.g., 1: 2: 3: 4: 5: 6-tribenzanthracene and 2': 3'-naphtha-3: 4-pyrene are both inert), but this is not invariably so. Both 1: 2: 3:4-and 3: 4: 8: 9-dibenzpyrene have pronounced carcinogenic activity. The influence of introducing oxygen and nitrogen into the molecule has been studied, although not very extensively so far. Here, also, the all-important factor is probably the position of substitution. Carcinogenic activity has been found in the meso amino and meso methoxy derivatives of 1: 2: 5: 6-dibenzanthracene, but complete inactivity was shown by 3-hydroxymethylcholanthrene, 4'-hydroxy-3: 4-benzpyrene, and their respective methyl ethers. On the other hand, Fieser and his collaborators have reported the production of tumours by 3-hydroxy-1: 2-benzanthracene; that is, by a hydroxy derivative of a non-carcinogenic hydrocarbon.
An interesting series of compounds in which various modifications are made in the molecules of 1: 2: 5: 6-dibenzanthracene and the very feebly carcinogenic 1: 2: 7: 8-dibenzanthracene is that represented by the preceding formulae. The structural modifications involve the introduction of nitrogen into the middle ring of the molecule, or contraction of this ring to a five-membered ring, or both of these changes. The first five of these compounds have all given tumours, although the latent period is very prolonged (about 300 days). The dibenzphenazine proved inactive, and Boyland and Brues, who tested the carbazole derivatives, found very slight activity in the 1: 2: 7: 8-dibenzcarbazole.
Carcinogenic Hydrocarbons not related to 1: 2-benzanthracene This brief survey may be conduded with a reference to recent experiments which show that the 1: 2-benzanthracene type of structure is not essential for carcinogenic activity among the polycyclic hydrocarbons. Fieser has, in the course of his experiments on the simplification of the methylcholanthrene molecule, prepared an analogue of cholanthrene, 5: 1 0-dimethylene-1: 2-cyclopentenoanthracene, in which the 1: 2-benz ring of cholanthrene is replaced by a five-membered carbon ring. This compound gave tumours in 3 out of 20 mice within 10 months of the commencement of injections of a solution in lard.
There are, moreover, indications that considerable carcinogenic potency may be shown by polycydic hydrocarbons unrelated to anthracene. Several years ago I synthesised 3: 4-benzphenanthrene and this compound gave tumours of the skin in a large proportion of the mice treated, but the latent period was as long as 15 months or so. This line of work is now being actively extended by my colleague, C. L. Hewett, who has found in 2-methyl-3:4-benzphenanthrene a carcinogenic compound which is almost as potent as cholanthrene, and he has also prepared 1: 2: 3: 4-dibenzphenanthrene which has begun to yield epithelial tumours after 4 months.
By condensing 1 -bromo-2-naphthylacetic acid with aromatic aldehydes and then bringing about cyclisation by elimination of hydrogen bromide with fused potash, Hewett has developed a method which is proving very useful in the synthesis of these hitherto relarH tively inaccessible 3:
Br is 4-benzphenanthrene Cfk2T2 C02 derivatives, e.g., It is evident that the capacity to induce malignant tumours is a property which is shared by many different compounds. It is impossible at the present stage to explain this property, and it seems useless to attempt to define any common feature of molecular structure. Nevertheless, the availability of a wide range of carcinogenic compounds and dosely related inactive substances has provided much material for the investigation of the mode of their biological action. Already there are several observations which may prove to be of considerable significance, and it seems justifiable to express the belief that the mechanism of carcinogenesis by these chemical substances will in due time be laid bare by further experimental work.
